FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953313196> ?p ?o ?g. }

• W2953313196 abstract "Background: Takayasu arteritis (TAK) is a chronic inflammatory disease, mainly affecting aorta and its major branches. Despite treatment with glucocorticoid and adjunctive immunosuppressive agent, relapse is common. Considering the high relapse rate, it is important to identify additional medications that may help sustain remission. Statins, as having anti-inflammatory and immunomodulartory effects, may be one such possibility. Objectives: To investigate the effect of statins on relapse of Takayasu arteritis (TAK), which frequently occurs after achievement of remission. Methods: We conducted a retrospective study on TAK patients with active disease, diagnosed between 2012 and 2017. Relapse was defined as recurrence of active disease after achieving remission. Demographic and clinical parameters of patients who experienced relapse were compared to those who did not. To identify factors associated with relapse, multivariate Cox regression analysis with stepwise backward elimination was performed. Inverse probability of treatment weighting (IPTW)-adjusted analysis was used to evaluate the influence of statins on relapse. Results: Of the total 74 TAK patients, 40 (54.1%) patients received statins, whereas 34 (45.9%) patients did not. Relapse was observed in 36 (48.6%) patients of the total 74 TAK patients. Compared with patients who did not experience relapse, patients who experienced relapse were younger (44.5±13.5 years vs 34.1±12.6 years, p=0.001), had lower prevalence of hypertension (63.2% vs 38.9%, p=0.037), more commonly had carotidynia (7.9% vs 27.8%, p=0.025), had higher LDL-cholesterol (84.8±18.8 mg/dl vs 100.5±26.1 mg/dl, p=0.010), and were less commonly taking statins (71.1% vs 36.1%, p=0.003). These variables were included in multivariate Cox regression analysis. The use of statins was significantly associated with lower risk of relapse (adjusted hazard ratio 0.260, 95% confidence interval 0.120–0.563, p=0.001). Furthermore, IPTW-adjusted analysis confirmed that statin use was associated with a lower risk of relapse (IPTW-adjusted hazard ratio 0.153, 95% confidence interval 0.038–0.616, p=0.008). Conclusion: In TAK, statins can be beneficial in reducing relapse rate after achieving remission. Covariates: age (continuous), hypertension (yes/no), carotidynia (yes/no), LDL-cholesterol (continuous), and statin use (yes/no) Disclosure of Interests: None declared" @default.
• W2953313196 created "2019-06-27" @default.
• W2953313196 creator A5001474613 @default.
• W2953313196 creator A5008432802 @default.
• W2953313196 creator A5017065616 @default.
• W2953313196 creator A5028672424 @default.
• W2953313196 creator A5031920226 @default.
• W2953313196 creator A5060150127 @default.
• W2953313196 creator A5079117039 @default.
• W2953313196 creator A5081895884 @default.
• W2953313196 date "2019-06-01" @default.
• W2953313196 modified "2023-09-26" @default.
• W2953313196 title "FRI0282 STATINS REDUCE RELAPSE RATE IN TAKAYASU ARTERITIS" @default.
• W2953313196 doi "https://doi.org/10.1136/annrheumdis-2019-eular.4705" @default.
• W2953313196 hasPublicationYear "2019" @default.
• W2953313196 type Work @default.
• W2953313196 sameAs 2953313196 @default.
• W2953313196 citedByCount "0" @default.
• W2953313196 crossrefType "proceedings-article" @default.
• W2953313196 hasAuthorship W2953313196A5001474613 @default.
• W2953313196 hasAuthorship W2953313196A5008432802 @default.
• W2953313196 hasAuthorship W2953313196A5017065616 @default.
• W2953313196 hasAuthorship W2953313196A5028672424 @default.
• W2953313196 hasAuthorship W2953313196A5031920226 @default.
• W2953313196 hasAuthorship W2953313196A5060150127 @default.
• W2953313196 hasAuthorship W2953313196A5079117039 @default.
• W2953313196 hasAuthorship W2953313196A5081895884 @default.
• W2953313196 hasBestOaLocation W29533131961 @default.
• W2953313196 hasConcept C126322002 @default.
• W2953313196 hasConcept C167135981 @default.
• W2953313196 hasConcept C2776015282 @default.
• W2953313196 hasConcept C2779134260 @default.
• W2953313196 hasConcept C2779291185 @default.
• W2953313196 hasConcept C2780841215 @default.
• W2953313196 hasConcept C2781343717 @default.
• W2953313196 hasConcept C71924100 @default.
• W2953313196 hasConcept C90924648 @default.
• W2953313196 hasConceptScore W2953313196C126322002 @default.
• W2953313196 hasConceptScore W2953313196C167135981 @default.
• W2953313196 hasConceptScore W2953313196C2776015282 @default.
• W2953313196 hasConceptScore W2953313196C2779134260 @default.
• W2953313196 hasConceptScore W2953313196C2779291185 @default.
• W2953313196 hasConceptScore W2953313196C2780841215 @default.
• W2953313196 hasConceptScore W2953313196C2781343717 @default.
• W2953313196 hasConceptScore W2953313196C71924100 @default.
• W2953313196 hasConceptScore W2953313196C90924648 @default.
• W2953313196 hasLocation W29533131961 @default.
• W2953313196 hasOpenAccess W2953313196 @default.
• W2953313196 hasPrimaryLocation W29533131961 @default.
• W2953313196 isParatext "false" @default.
• W2953313196 isRetracted "false" @default.
• W2953313196 magId "2953313196" @default.
• W2953313196 workType "article" @default.